Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)
China flag China · Delayed Price · Currency is CNY
13.75
-0.13 (-0.94%)
Jul 30, 2026, 10:55 AM CST

SHE:002020 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
-530.71316.271,4611,5481,561
Trading Asset Securities
-318.96827.66150.96366.89422.4
Cash & Short-Term Investments
849.67849.671,1441,6121,9151,983
Cash Growth
21.65%-25.72%-29.03%-15.85%-3.41%-8.38%
Accounts Receivable
-881.12852.02612.58509.57510.67
Other Receivables
-49.2455.2651.4459.13103.81
Receivables
-930.36907.27664.02568.7614.47
Inventory
-766.15792.72652.69773.7677.69
Prepaid Expenses
-3.223.363.72.520.81
Other Current Assets
-751.4157.5421.5620.8817.82
Total Current Assets
-3,3012,9053,3543,2813,294
Property, Plant & Equipment
-2,2812,1882,3001,6321,297
Long-Term Investments
-1,4882,1611,1241,134882.21
Goodwill
-335.6348.48348.48348.48348.48
Other Intangible Assets
-431.89382.26401.26418.59157
Long-Term Deferred Tax Assets
-79.2383.5680.9875.1168.64
Long-Term Deferred Charges
-38.9358.7321.226.7155.95
Other Long-Term Assets
-167.59351.9356.72446.73443.95
Total Assets
-8,1248,4797,9877,3636,547

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
-666.34880.79941.16719.12449.79
Accrued Expenses
-225.72198.28206.39187.72189.47
Short-Term Debt
-284.39281.36279.09238.58148.33
Current Portion of Long-Term Debt
----0.050.27
Current Portion of Leases
-6.6313.311.8614.6914.66
Current Income Taxes Payable
-41.6589.1844.359.9950.25
Current Unearned Revenue
-56.4556.4853.3581.0147.61
Other Current Liabilities
-625.72615.12538.61514.23521.88
Total Current Liabilities
-1,9072,1352,0751,8151,422
Long-Term Debt
-----0.04
Long-Term Leases
-22.6323.1331.2342.9830.62
Long-Term Unearned Revenue
-263.91264.59268.81270.6128.73
Long-Term Deferred Tax Liabilities
-58.9654.3368.459.6865.44
Other Long-Term Liabilities
-0.861.193.21.940.74
Total Liabilities
-2,2532,4782,4462,1911,648

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
-861.03861.03861.03861.03905.32
Additional Paid-In Capital
-1,7231,7231,7231,7202,236
Retained Earnings
-3,8413,3682,9142,5542,150
Treasury Stock
--608.78----437.62
Comprehensive Income & Other
-16.6517.1713.8611.318.05
Total Common Equity
5,8335,8335,9705,5125,1464,862
Minority Interest
-37.2332.0427.7825.8537.72
Shareholders' Equity
5,8705,8706,0025,5405,1724,899
Total Liabilities & Equity
-8,1248,4797,9877,3636,547

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
313.65313.65317.79322.18296.3193.92
Net Cash (Debt)
536.02536.02826.131,2901,6191,789
Net Cash Growth
13.29%-35.12%-35.94%-20.35%-9.51%-4.00%
Net Cash Per Share
0.650.650.961.501.882.19
Filing Date Shares Outstanding
826.02813.76861.03861.03861.03861.03
Total Common Shares Outstanding
826.02813.76861.03861.03861.03861.03
Working Capital
-1,394770.261,2791,4661,872
Book Value Per Share
7.177.176.936.405.985.65
Tangible Book Value
5,0665,0665,2394,7634,3794,356
Tangible Book Value Per Share
6.226.226.085.535.095.06
Land
----0.21--
Buildings
-1,7971,6291,388934.82889.16
Machinery
-1,8401,7541,4121,219946.45
Construction In Progress
-52.7113.62482.06284.91161.34